# Case Report: Novel truncating PPM1D variant in a dichorionic diamniotic (DCDA) twin with Jansen-de Vries syndrome. an updated perspective

**Authors:** Francisco Javier Merida De la Torre, Javier Porta Pelayo, Inmaculada Ortiz-Martín

PMC · DOI: 10.3389/fgene.2025.1601752 · Frontiers in Genetics · 2025-06-24

## TL;DR

A 6-year-old boy with a rare genetic mutation in PPM1D shows symptoms of Jansen-de Vries syndrome, highlighting the importance of genetic testing in diagnosing neurodevelopmental disorders.

## Contribution

The case presents a novel PPM1D variant in a twin with JDVS, emphasizing the value of genetic testing and phenotypic variability in diagnosis.

## Key findings

- A de novo frameshift mutation (c.1411_1412del) in PPM1D was identified in one twin with JDVS-like symptoms.
- The twin without the mutation had milder symptoms and was discharged from mental health services.
- Trio-whole-exome sequencing confirmed the diagnostic utility in neurodevelopmental disorders with overlapping features.

## Abstract

Jansen-de Vries syndrome (JDVS) is a rare autosomal dominant neurodevelopmental disorder caused by truncating variants in exons 5 and 6 of the PPM1D gene. Its diagnosis is often delayed due to symptom overlap with more common conditions such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). This case report highlights the unique presentation of JDVS in one of a pair of dichorionic diamniotic (DCDA) twin brothers, both with ASD/ADHD, underscoring the diagnostic value of genetic testing.

A 6-year-old boy presented with delayed language development, learning difficulties, behavioral issues, restrictive eating, and impaired autonomy. His twin brother, although also diagnosed with ASD/ADHD, exhibited milder symptoms. Trio-whole-exome sequencing revealed a de novo frameshift mutation (c.1411_1412del) in PPM1D in the proband, classified as pathogenic. The brother had no such variant.

The proband received multidisciplinary interventions including behavioral therapy and speech support. Follow-up showed improvements in language, sleep, and academic performance, though behavioral and sphincter issues persist. The twin without the mutation was discharged from mental health services, while his brother remains under annual review.

This case emphasizes the expanding phenotypic spectrum of JDVS and illustrates the diagnostic value of trio-WES in neurodevelopmental disorders with overlapping features. It also highlights the potential for discordant phenotypic expression in twins and the need for individualized diagnostic assessment.

## Linked entities

- **Genes:** PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D) [NCBI Gene 8493]
- **Diseases:** Jansen-de Vries syndrome (MONDO:0044318), autism spectrum disorder (MONDO:0005258), attention-deficit/hyperactivity disorder (MONDO:0007743)

## Full-text entities

- **Genes:** PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D) [NCBI Gene 8493] {aka IDDGIP, JDVS, PP2C-DELTA, WIP1}
- **Diseases:** autosomal dominant neurodevelopmental disorder (MESH:D002658), ASD (MESH:D000067877), restrictive eating (MESH:D002313), impaired autonomy (MESH:D060825), learning difficulties (MESH:D007859), JDVS (OMIM:617450), ADHD (MESH:D001289), delayed language development (MESH:D007805)
- **Mutations:** c.1411_1412del

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12235261/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12235261/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12235261/full.md

---
Source: https://tomesphere.com/paper/PMC12235261